For media enquiries, please contact email@example.com
PhAMA Position on Medicines Price Control In Malaysia
PhAMA Position Papers on Intellectual Property [ Part 1 | Part 2 | Part 3 | Part 4 ]
Value-Based Medicines For Improved Patient Access in Malaysia White Paper (Updated November 2019)
PhAMA Position Statement on Prescription and Dispensing Separation
Building Greater Access to Innovative Medicines - What is Next for Malaysia?
Is Reference Pricing Right for Malaysia?
Phama Position on Biosimilar Medicines
Good Pharmaceutical Trading Practice Guideline (GPTP) Joint Industry Understanding
PhAMA's Position on Halal Pharmaceutical
[White Paper] Economic Transformation Program (ETP) Entry Point Project (EPP) 2
PhAMA Position Paper on Generic Medicines